No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.
Biocon Biologics Launches Biosimilar Etanercept in Australia
On 23 July 2025, Biocon Biologics announced that it has launched Nepexto®, biosimilar to Amgen/Pfizer’s Enbrel® (etanercept), in Australia. Nepexto® was approved by Australia’s